This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Murman, D. L. Search for Related Content PubMed PubMed Citation Articles by Murman, D. L. Social Bookmarking                   What's this?

The Costs of Caring: Medical Costs of Alzheimer's Disease and The Managed Care Environment

This review summarizes the medical costs associated with Alzheimer's disease (AD) and related dementias, as well as the payers responsible for these medical costs in the US health care system. It is clear from this review that AD and related dementias are associated with substantial medical costs. The payers responsible for a majority of these costs are families of patients with AD and the US government through the Medicare and Medicaid programs. In an attempt to control expenditures, Medicare and Medicaid have turned to managed care principles and managed care organizations. The increase in "managed" dementia care gives rise to several potential problems for patients with AD, along with many opportunities for systematic improvement in the quality of dementia care. Evidence-based disease management programs provide the greatest opportunities for improving managed dementia care but will require the development of dementia-specific quality of care measures to evaluate and continually improve them. (J Geriatr Psychiatry Neurol 2001; 14:168-178).

Journal of Geriatric Psychiatry and Neurology, Vol. 14, No. 4, 168-178 (2001)
DOI: 10.1177/089198870101400402


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?